Patient Management

2074 questions

All types2,074 Multiple choice1,048 Multiple select393 Matching221 Ordering412

A 72-year-old man comes to the clinic for a follow-up visit 4 weeks after being diagnosed with symptomatic atrial fibrillation. His medical history includes a mechanical aortic valve replacement performed 5 years ago, essential hypertension, and hyperlipidemia. His daily medications are warfarin, simvastatin, and lisinopril. His international normalized ratio (INR) has been stable between 2.0 and 3.0 for the past two years. Two weeks ago, his cardiologist started him on oral amiodarone for rhythm control. The patient currently feels well and reports no palpitations, dyspnea, cough, muscle pain, or unusual bruising. Vital signs are within normal limits. To appropriately evaluate and monitor this patient's pharmacotherapy, which of the following laboratory parameters or diagnostic tests are indicated at this time and periodically during maintenance therapy? Select all that apply.

Select all that apply

Serum thyroid-stimulating hormone (TSH)

International normalized ratio (INR)

Hepatic aminotransferases (AST and ALT)

Activated partial thromboplastin time (aPTT)

Scheduled pulmonary function tests (PFTs)

Routine serum creatine kinase (CK)

Show answer & explanation

Answer: Serum thyroid-stimulating hormone (TSH); International normalized ratio (INR); Hepatic aminotransferases (AST and ALT)

Answer

The indicated parameters for ongoing monitoring are serum thyroid-stimulating hormone (TSH), international normalized ratio (INR), and hepatic aminotransferases (AST and ALT).

Amiodarone is a class III antiarrhythmic with a complex toxicity profile and significant drug-drug interactions. Because it contains iodine and affects thyroid hormone metabolism, TSH must be monitored at baseline and every 6 months. It can also cause insidious hepatotoxicity, necessitating AST and ALT checks at baseline and every 6 months. Furthermore, amiodarone is a potent inhibitor of multiple cytochrome P450 enzymes, particularly CYP2C9. Warfarin is metabolized primarily by CYP2C9; therefore, adding amiodarone significantly increases serum warfarin concentrations, elevating the risk of bleeding. The INR must be monitored closely upon amiodarone initiation, and an empiric warfarin dose reduction of 25% to 50% is standard practice.

Step-by-Step Solution

Identify the primary medication being initiated and its inherent toxicity profile.

The patient was recently started on amiodarone, a medication with known thyroid, hepatic, and pulmonary toxicities.

Amiodarone requires strict baseline and periodic surveillance to detect asymptomatic organ toxicity.

Determine the recommended routine monitoring intervals for amiodarone.

Guidelines recommend checking TSH and AST/ALT at baseline and every 6 months. A chest X-ray is required annually, but routine PFTs are not required unless symptoms develop.

Periodic screening prevents progression of asymptomatic end-organ damage caused by amiodarone.

Evaluate potential pharmacokinetic interactions between the new medication and the patient's existing regimen (warfarin, simvastatin, lisinopril).

Amiodarone inhibits CYP2C9 (increasing warfarin levels) and CYP3A4 (increasing simvastatin levels).

Recognizing drug-drug interactions is critical for anticipating adverse events like bleeding or myopathy.

Determine the appropriate monitoring strategy for the identified drug interactions.

The interaction with warfarin requires close, frequent monitoring of the INR (and typically a dose reduction of warfarin). The interaction with simvastatin requires a simvastatin dose reduction, but routine CK monitoring is not indicated unless the patient is symptomatic.

Lab monitoring must align with evidence-based guidelines; over-ordering confirmatory tests for asymptomatic patients leads to unnecessary interventions.

Key Concept

Patients initiated on amiodarone require periodic monitoring of thyroid and liver function, as well as vigilant monitoring of the INR if co-administered with warfarin due to potent CYP2C9 inhibition.

Question 422Question →

A 73-year-old male retired postal worker is brought to the clinic by his son due to a 14-month history of progressive memory decline. The son reports that the patient repeatedly asks the same questions, has gotten lost twice while driving to a familiar local grocery store, and recently made several significant errors while balancing his checkbook. The patient has a history of well-controlled hypertension and osteoarthritis. He takes lisinopril and occasional acetaminophen. Vital signs are normal. Physical and detailed neurological examinations reveal no focal deficits, resting tremor, or gait abnormalities. He scores 19/30 on the Montreal Cognitive Assessment (MoCA), losing points primarily on delayed recall, visuospatial drawing, and attention. Which of the following tests are indicated as part of the routine initial diagnostic workup for this patient's cognitive decline? (Select all that apply)

Select all that apply

Serum thyroid-stimulating hormone (TSH) level

Serum vitamin B12 level

Magnetic resonance imaging (MRI) of the brain

Apolipoprotein E (APOE) genotyping

Fluorodeoxyglucose-positron emission tomography (FDG-PET) scan of the brain

Cerebrospinal fluid (CSF) analysis for amyloid-beta and tau proteins

Show answer & explanation

Answer: Serum thyroid-stimulating hormone (TSH) level; Serum vitamin B12 level; Magnetic resonance imaging (MRI) of the brain

Answer

The correct initial diagnostic evaluation includes a serum TSH level, a serum vitamin B12 level, and an MRI of the brain.

The initial evaluation of a patient with objective cognitive impairment requires assessing for reversible causes and ruling out structural brain lesions. Standard medical guidelines mandate routine laboratory testing with serum vitamin B12 and TSH levels, as deficiencies in these domains can independently mimic or exacerbate neurocognitive disorders. Additionally, structural neuroimaging, preferably an MRI of the brain (or non-contrast CT if MRI is contraindicated), is indicated for all patients with new-onset cognitive decline. This imaging evaluates for cerebrovascular disease, tumors, subdural hematomas, and normal pressure hydrocephalus, while establishing a baseline of regional cerebral atrophy.

Step-by-Step Solution

Analyze the patient's clinical presentation and assessment scores.

The patient demonstrates an insidious, progressive cognitive decline impairing instrumental activities of daily living, consistent with a major neurocognitive disorder (dementia), likely Alzheimer disease.

Establishing the clinical syndrome is necessary before determining the appropriate diagnostic algorithms.

Identify the guideline-directed initial diagnostic workup for new-onset dementia.

Current guidelines mandate evaluating for reversible metabolic/endocrine causes and ruling out structural brain pathology.

Certain treatable conditions can mimic or exacerbate neurocognitive decline and must be excluded.

Select the specific modalities that fulfill the preliminary workup criteria.

Serum B12 and TSH are the standard initial laboratory tests. MRI of the brain is the preferred structural imaging modality.

These tests provide a high-yield, non-invasive foundation for the diagnosis without prematurely exposing the patient to unnecessary advanced imaging or invasive procedures.

Key Concept

Standard initial diagnostic workup for cognitive impairment and dementia

Estimated Time:1m 0s

Question 423Question →

A 48-year-old woman presents to the emergency department with severe right-sided flank pain, chills, and confusion. Her temperature is $39.2^\circ\text{C}$ ( $102.6^\circ\text{F}$ ), blood pressure is $88/54\text{ mmHg}$ , pulse is $122/\text{min}$ , and respiratory rate is $22/\text{min}$ . Physical examination reveals severe right costovertebral angle tenderness. A non-contrast CT scan of the abdomen and pelvis demonstrates a $1.2\text{ cm}$ calculus in the proximal right ureter with severe hydronephrosis and perinephric stranding. Arrange the following steps in the most appropriate chronological order for managing this patient's condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological management order is: 1) Initiate intravenous crystalloid fluid resuscitation and obtain blood and urine cultures, 2) Administer broad-spectrum intravenous antibiotics, 3) Perform emergent decompression of the collecting system, and 4) Perform definitive stone removal.

The correct sequence for managing an infected obstructing ureteral calculus with severe sepsis aligns with standard resuscitation guidelines: Airway/Breathing/Circulation stabilization (fluids and cultures), early empiric treatment (antibiotics), emergent source control (decompression), and delayed definitive management (stone extraction) once the patient is clinically stable.

Step-by-Step Solution

Recognize severe urosepsis and initial shock state.

The patient requires immediate hemodynamic stabilization with IV fluids and acquisition of cultures before therapies are administered.

Fluid resuscitation supports perfusion, while cultures ensure correct antibiotic targeting later without being altered by early empiric treatments.

Provide empiric medical therapy for the infection.

Broad-spectrum IV antibiotics are administered.

Early antibiotic administration is a cornerstone of sepsis management and significantly reduces mortality when given within the first hour of recognition.

Achieve surgical source control.

The collecting system is decompressed using a percutaneous nephrostomy tube or a retrograde ureteral stent.

Medical therapy alone will fail if the infected, obstructed renal pelvis is not drained. The pus under pressure must be relieved emergently.

Address the underlying structural cause.

Definitive stone removal via ureteroscopy or lithotripsy is planned for a later date.

Attempting to break or extract the stone during an active infection can cause systemic dissemination of bacteria leading to septic shock and death. This step must wait until the patient has fully recovered from the acute infection.

Key Concept

The management of an infected obstructing ureteral stone requires a strict sequence: initial medical stabilization (fluids/cultures), empiric antibiotics, emergent source control (decompression), and finally, delayed definitive stone removal.

Question 424Question →

A 29-year-old woman is admitted to the intensive care unit with severe agitation, profuse diaphoresis, and a temperature of 39.8°C (103.6°F). Her heart rate is 158/min, blood pressure is 152/74 mm Hg, and respiratory rate is 24/min. Physical examination reveals a diffusely enlarged thyroid gland, a fine resting tremor, and hyperreflexia. She has a history of Graves disease but has been nonadherent to medical therapy for the past eight months. A diagnosis of thyroid storm is established.

Arrange the following pharmacologic interventions in the most appropriate chronological order of administration to safely and effectively manage her condition.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: 1) Intravenous propranolol, 2) Oral propylthiouracil, 3) Oral potassium iodide.

The precise chronological protocol for thyroid storm is dictated by physiological mechanisms. Intravenous propranolol is given immediately for rapid mitigation of life-threatening sympathetic hyperactivity and to decrease peripheral T4 to T3 conversion. Oral propylthiouracil is then given to inhibit thyroid peroxidase, halting the synthesis of new hormone. Finally, oral potassium iodide is given at least one hour later to trigger the Wolff-Chaikoff effect, blocking the release of pre-stored hormone from the gland.

Step-by-Step Solution

Stabilize autonomic hyperactivity.

Intravenous propranolol is administered.

Patients in thyroid storm are at high risk for high-output heart failure and fatal arrhythmias due to intense sympathetic overstimulation. Beta-blockade is the most urgent intervention.

Inhibit de novo thyroid hormone synthesis.

Oral propylthiouracil (PTU) is administered.

Before the release of preformed hormone can be safely blocked with iodine, the synthesis pathway must be shut down to prevent the gland from using the new iodine to manufacture even more hormone.

Block the release of preformed thyroid hormone.

Oral potassium iodide is administered.

Administered at least one hour after PTU, the high dose of iodine leverages the Wolff-Chaikoff effect to halt the release of already manufactured T3 and T4 from the colloid into the bloodstream.

Key Concept

In the management of thyroid storm, sympathetic blockade (propranolol) is the immediate priority, followed by blocking hormone synthesis (propylthiouracil), which must strictly precede blocking hormone release (potassium iodide) to avoid paradoxically fueling hormone production.

Estimated Time:1m 30s

Question 425Question →

A 72-year-old man is evaluated in the emergency department for a 3-day history of progressively worsening productive cough, shortness of breath, and confusion. His medical history includes hypertension and type 2 diabetes mellitus. He lives with his wife, who reports that he has been disoriented since this morning.

Temperature is 38.8°C (101.8°F), blood pressure is 88/56 mmHg, pulse is 112/min, and respiratory rate is 32/min. Pulse oximetry shows an oxygen saturation of 88% on room air. He is oriented to person only. Lung auscultation reveals crackles over the right middle and lower lung fields.

Laboratory studies show:
Leukocyte count: 18,500/mm³
Blood urea nitrogen: 38 mg/dL
Creatinine: 1.5 mg/dL

A chest radiograph demonstrates right middle and lower lobe consolidations. The patient receives supplemental oxygen via a non-rebreather mask, bringing his oxygen saturation to 95%. He is given a 2-liter intravenous bolus of normal saline, after which his blood pressure improves slightly to 92/58 mmHg. Empiric intravenous antibiotics are initiated.

Which of the following is the most appropriate next step regarding the disposition of this patient?

Admission to the medical intensive care unit

Admission to the general medical ward with continuous pulse oximetry monitoring

Placement in an emergency department observation unit for 24 hours

Discharge to a skilled nursing facility with a prescription for parenteral antibiotics

Delay admission to perform a computed tomography scan of the chest to rule out an abscess

Show answer & explanation

Answer: Admission to the medical intensive care unit

Answer

Admission to the medical intensive care unit

The correct answer is admission to the medical intensive care unit (ICU). This patient has severe community-acquired pneumonia (CAP). According to the Infectious Diseases Society of America/American Thoracic Society (IDSA/ATS) guidelines, direct admission to an ICU is recommended for patients who have at least 1 major criterion (e.g., need for invasive mechanical ventilation, septic shock requiring vasopressors) or at least 3 minor criteria. This patient meets at least 5 minor criteria: confusion, uremia (BUN > 20 mg/dL), respiratory rate ≥ 30/min, hypotension requiring aggressive fluid resuscitation, and multilobar infiltrates on radiography. Therefore, he exhibits a high risk of continued clinical deterioration and requires the high-level hemodynamic and respiratory monitoring provided exclusively in an ICU setting.

Step-by-Step Solution

Identify the primary clinical diagnosis.

The patient has acute community-acquired pneumonia (CAP) presenting with hypoxia, hypotension, and altered mental status.

Establishing the working diagnosis determines which risk stratification tool to apply for disposition.

Apply objective severity criteria to determine the required level of care.

Using the IDSA/ATS criteria for severe CAP, the patient has 5 minor criteria: respiratory rate ≥ 30/min, multilobar infiltrates, confusion, BUN ≥ 20 mg/dL, and hypotension requiring aggressive fluid resuscitation.

Severity scores remove subjectivity and align patient acuity with the correct hospital unit capabilities.

Select the appropriate disposition setting based on the calculated severity.

Because the patient meets at least 3 minor criteria, he requires direct admission to the intensive care unit.

Guidelines mandate ICU admission for patients with severe CAP to reduce mortality and appropriately manage impending respiratory or hemodynamic collapse.

Key Concept

The decision-making process for appropriate patient disposition relies on synthesizing clinical severity scores (e.g., IDSA/ATS criteria for severe community-acquired pneumonia) with the patient's functional status to ensure they are transitioned to a care setting equipped for their acuity.

Question 426Question →

A 72-year-old woman is brought to the emergency department from a skilled nursing facility due to severe confusion and high fever. Her temperature is 39.4°C (102.9°F), blood pressure is 82/50 mmHg, pulse is 118/min, and respirations are 22/min. Physical examination reveals scleral icterus and right upper quadrant abdominal tenderness with guarding. Laboratory studies show a leukocyte count of 18,000/mm³, total bilirubin of 6.5 mg/dL, direct bilirubin of 5.0 mg/dL, and alkaline phosphatase of 450 U/L. A bedside right upper quadrant ultrasound demonstrates a common bile duct dilated to 12 mm containing echogenic material consistent with stones; there is no gallbladder wall thickening. The patient is intubated for airway protection. After the rapid administration of 3 liters of normal saline and initiation of broad-spectrum intravenous antibiotics, her blood pressure improves marginally to 88/55 mmHg, prompting the initiation of a norepinephrine infusion. Which of the following is the most appropriate next step in management?

Endoscopic retrograde cholangiopancreatography

Magnetic resonance cholangiopancreatography

Emergent open cholecystectomy with common bile duct exploration

Percutaneous transhepatic cholangiography

Continued medical management and intensive care unit observation

Show answer & explanation

Answer: Endoscopic retrograde cholangiopancreatography

Answer

Endoscopic retrograde cholangiopancreatography

The correct answer is endoscopic retrograde cholangiopancreatography (ERCP). This patient presents with Reynolds pentad—fever, jaundice, right upper quadrant pain, hypotension, and altered mental status—which signifies severe acute (suppurative) ascending cholangitis. The pathophysiology involves bacterial infection in the setting of complete biliary obstruction, most commonly due to choledocholithiasis, leading to purulent material under high pressure within the biliary tree. This causes rapid bacterial translocation into the bloodstream, resulting in septic shock. While initial management involves airway protection, fluid resuscitation, vasopressors, and broad-spectrum intravenous antibiotics, medical therapy alone is insufficient. Emergent biliary decompression is mandatory to remove the source of infection and reverse the shock state. ERCP is the standard-of-care, first-line procedure as it is minimally invasive, diagnostic, and highly therapeutic (allowing for sphincterotomy, stone extraction, and stent placement).

Step-by-Step Solution

Identify the clinical syndrome from the patient's presentation.

The patient has fever, jaundice, right upper quadrant pain, hypotension, and altered mental status.

These five signs constitute Reynolds pentad, which is pathognomonic for severe acute (suppurative) ascending cholangitis.

Assess the severity of the disease and the patient's hemodynamic status.

The patient requires intubation, aggressive fluid resuscitation, and vasopressors, indicating severe, life-threatening disease.

Determining severity dictates whether the patient can be managed with antibiotics alone temporarily or requires emergent procedural intervention.

Select the appropriate procedural intervention.

Urgent biliary decompression via endoscopic retrograde cholangiopancreatography is selected.

Endoscopic intervention provides minimally invasive, highly effective drainage of the infected bile duct, which is mandatory to reverse the shock state in severe cholangitis.

Key Concept

Patients presenting with severe acute cholangitis (Reynolds pentad) require emergent biliary decompression, most commonly achieved via endoscopic retrograde cholangiopancreatography, alongside hemodynamic resuscitation and broad-spectrum antibiotics.

Question 427Question →

A construction worker is transported to the trauma center by helicopter after falling approximately 30 feet from scaffolding. On arrival, the patient is obtunded but groans to painful stimuli. Vital signs demonstrate a blood pressure of 68/40 mm Hg, a heart rate of 148/min, and a respiratory rate of 28/min. Oxygen saturation is 95% on a non-rebreather mask. The airway is patent, and breath sounds are symmetric bilaterally. The abdomen is distended, and gentle lateral compression of the iliac crests reveals profound mechanical instability. A bedside focused assessment with sonography for trauma (FAST) reveals no free intraperitoneal fluid. Which of the following simultaneous initial management steps are most appropriate for this patient? (Select exactly 2 options)

Select all that apply

Application of a noninvasive pelvic circumferential compression device

Initiation of a massive transfusion protocol with uncrossmatched blood products

Immediate transport to the radiology suite for a computed tomography scan of the abdomen and pelvis

Initiation of a continuous intravenous norepinephrine infusion

Performance of a retrograde urethrogram

Show answer & explanation

Answer: Application of a noninvasive pelvic circumferential compression device; Initiation of a massive transfusion protocol with uncrossmatched blood products

Answer

The correct simultaneous initial steps are the application of a noninvasive pelvic circumferential compression device and the initiation of a massive transfusion protocol with uncrossmatched blood products.

This patient presents with profound hemorrhagic shock following a high-altitude fall, exhibiting a mechanically unstable pelvis. A negative FAST exam in this context highly suggests massive retroperitoneal hemorrhage resulting from a pelvic ring disruption. In unstable patients with suspected severe pelvic fractures, immediate mechanical stabilization using a pelvic binder reduces pelvic volume, promoting the tamponade of venous bleeding and bony surfaces. Simultaneously, aggressive volume resuscitation using balanced blood products via a massive transfusion protocol is critical to restore intravascular volume, improve oxygen-carrying capacity, and prevent the trauma-induced coagulopathy that worsens with large-volume crystalloid administration.

Step-by-Step Solution

Assess the patient's hemodynamic status and mechanism of injury.

The patient is in profound shock (BP 68/40, HR 148) following a high-impact fall with an unstable pelvis.

Identifying the severity of shock establishes the immediate need for aggressive resuscitation over diagnostic imaging.

Interpret the negative FAST exam in the context of an unstable pelvis.

The absence of intraperitoneal fluid suggests the source of massive hemorrhage is likely retroperitoneal, originating from the disrupted pelvic ring.

This localizes the primary source of bleeding and guides specific mechanical interventions.

Determine the optimal simultaneous stabilization interventions.

Select mechanical tamponade (pelvic binder) and optimal fluid replacement (massive transfusion protocol) as the dual life-saving measures.

These interventions simultaneously control the rate of bleeding and restore oxygen-carrying capacity.

Key Concept

Initial stabilization of suspected massive pelvic hemorrhage requires simultaneous mechanical volume reduction (pelvic binder) and hemodynamic resuscitation with blood products.

Question 428Question →

A 29-year-old woman, gravida 2, para 1, at 28 weeks gestation, presents to the emergency department reporting a sudden onset of shortness of breath and right-sided chest pain that worsens with deep inspiration. She also notes that her right leg has felt "heavy" and painful since yesterday. Her pregnancy has been uncomplicated thus far, and she takes only prenatal vitamins. Vital signs show a temperature of 37.0°C (98.6°F), heart rate of 115/min, respiratory rate of 24/min, blood pressure of 118/76 mmHg, and oxygen saturation of 94% on room air. Physical examination reveals clear lungs bilaterally. The right calf is visibly enlarged, erythematous, and tender to palpation compared to the left. Which of the following is the most appropriate next step in the diagnostic workup?

Compression ultrasonography of the lower extremities

Computed tomography pulmonary angiography

Measurement of serum D-dimer level

Ventilation-perfusion (V/Q) lung scan

Chest radiography

Show answer & explanation

Answer: Compression ultrasonography of the lower extremities

Answer

Compression ultrasonography of the lower extremities

The correct answer is compression ultrasonography of the lower extremities. This patient's presentation is highly suspicious for a pulmonary embolism originating from a deep vein thrombosis. In pregnant patients, diagnostic sequencing must carefully balance accurate diagnosis with minimizing radiation exposure to the fetus and the maternal breast tissue. If a pregnant patient with suspected pulmonary embolism has signs or symptoms of deep vein thrombosis (such as unilateral leg swelling and pain), the most appropriate initial diagnostic step is bilateral compression ultrasonography. A positive finding confirms the diagnosis of venous thromboembolism and provides sufficient justification to initiate full therapeutic anticoagulation. Consequently, this eliminates the need to perform chest imaging (like a V/Q scan or CT pulmonary angiography), entirely sparing the patient and fetus from radiation.

Step-by-Step Solution

Analyze the clinical presentation.

The patient is pregnant and presents with classic signs of pulmonary embolism (pleuritic chest pain, tachycardia, dyspnea) along with concurrent signs of deep vein thrombosis (unilateral leg swelling, erythema, and tenderness).

Identifying both the suspected condition and the patient's unique physiological state (pregnancy) is critical to selecting safe and appropriate diagnostic modalities.

Determine the diagnostic algorithm for suspected pulmonary embolism in pregnancy.

Because the patient has symptoms of deep vein thrombosis, the algorithm prioritizes evaluating the leg first with compression ultrasonography.

If the compression ultrasound is positive for deep vein thrombosis, the diagnosis of venous thromboembolism is confirmed, and therapeutic anticoagulation can be initiated immediately without the need for further chest imaging, thereby completely avoiding radiation exposure.

Key Concept

Diagnostic sequencing for suspected pulmonary embolism in pregnancy prioritizes bilateral compression ultrasonography if deep vein thrombosis symptoms are present, to potentially confirm venous thromboembolism and avoid radiation exposure from chest imaging.

Question 429Question →

A $74$ -year-old female patient in the intensive care unit is evaluated for a new-onset fever and right upper quadrant abdominal pain. She was admitted $10$ days ago for severe bacterial pneumonia requiring mechanical ventilation. Her temperature is $39.2^\circ\text{C}$ ( $102.6^\circ\text{F}$ ), blood pressure is $85/54\text{ mm Hg}$ , and pulse is $126/\text{min}$ . Physical examination shows right upper quadrant tenderness and guarding. Laboratory studies reveal a leukocyte count of $19,000/\text{mm}^3$ . A bedside right upper quadrant ultrasound demonstrates a thickened gallbladder wall, pericholecystic fluid, and an absence of gallstones. The patient is currently receiving broad-spectrum intravenous antibiotics and vasopressor support. Which of the following is the most appropriate next step in management?

Placement of a percutaneous cholecystostomy tube

Immediate open cholecystectomy

Transfer to the radiology suite for a computed tomography scan

Hepatobiliary iminodiacetic acid (HIDA) scan

Endoscopic retrograde cholangiopancreatography

Show answer & explanation

Answer: Placement of a percutaneous cholecystostomy tube

Answer

Placement of a percutaneous cholecystostomy tube

The patient has acute acalculous cholecystitis, a severe inflammation of the gallbladder seen typically in critically ill, hospitalized patients (e.g., those with sepsis, burns, or on prolonged mechanical ventilation). Although the definitive treatment for gallbladder inflammation is a cholecystectomy, this patient is hemodynamically unstable, dependent on vasopressors, and requiring mechanical ventilation. These factors make her an extremely poor surgical candidate with prohibitively high operative mortality. Therefore, the most appropriate procedural intervention is the placement of a percutaneous cholecystostomy tube. This procedure can often be performed at the bedside, providing immediate, life-saving decompression of the infected gallbladder and achieving source control while minimizing physiologic stress.

Step-by-Step Solution

Identify the patient's diagnosis based on the clinical presentation and imaging.

The combination of fever, right upper quadrant pain, leukocytosis, and an ultrasound showing gallbladder inflammation without stones in a critically ill patient indicates acute acalculous cholecystitis.

Establishing the correct diagnosis is the prerequisite for determining the appropriate intervention.

Assess the patient's surgical risk and hemodynamic stability.

The patient is in shock, requiring vasopressors and mechanical ventilation, making her an extremely poor candidate for general anesthesia and surgery.

The choice between definitive surgery and temporizing procedural drainage depends directly on the patient's stability.

Select the safest, most effective procedural intervention for source control.

Percutaneous drainage is chosen over cholecystectomy.

It provides immediate gallbladder decompression and source control with minimal physiological stress compared to open or laparoscopic surgery.

Key Concept

Procedural management of acute acalculous cholecystitis in critically ill, unstable patients relies on percutaneous cholecystostomy rather than surgical cholecystectomy.

Question 430Question →

A 45-year-old man is admitted to the intensive care unit for initiation of induction chemotherapy for newly diagnosed Burkitt lymphoma. He has a massive retroperitoneal tumor burden and baseline renal impairment with a serum creatinine of $1.8 \text{ mg/dL}$ . Recognizing his high risk for tumor lysis syndrome (TLS), the medical team initiates aggressive intravenous hydration and administers a dose of rasburicase prior to starting the chemotherapy regimen.

Twelve hours after the initiation of chemotherapy, the patient is noted to be oliguric, with a urine output of only $20 \text{ mL/hr}$ over the last 6 hours. Continuous telemetric monitoring reveals new-onset peaked T waves.

Stat laboratory studies are obtained:

Laboratory Parameter	Value	Reference Range
Potassium	$6.8 \text{ mEq/L}$	$3.5-5.0 \text{ mEq/L}$
Phosphorus	$8.5 \text{ mg/dL}$	$2.5-4.5 \text{ mg/dL}$
Calcium (total)	$6.4 \text{ mg/dL}$	$8.4-10.2 \text{ mg/dL}$
Uric acid	$2.5 \text{ mg/dL}$	$3.0-8.0 \text{ mg/dL}$
Creatinine	$3.2 \text{ mg/dL}$	$0.7-1.3 \text{ mg/dL}$

Based on the patient's monitoring data, which of the following are the most appropriate NEXT STEPS in the treatment evaluation and management of this patient? (Select the 2 correct answers)

Select all that apply

Administer intravenous calcium gluconate

Consult nephrology for emergent renal replacement therapy

Administer a continuous infusion of sodium bicarbonate for urine alkalinization

Administer an additional dose of intravenous rasburicase

Administer oral sevelamer to acutely lower serum phosphorus

Administer high-volume intravenous normal saline at 250 mL/hr to force diuresis

Show answer & explanation

Answer: Administer intravenous calcium gluconate; Consult nephrology for emergent renal replacement therapy

Answer

The correct next steps are to administer intravenous calcium gluconate and consult nephrology for emergent renal replacement therapy.

The correct next steps address two simultaneous, life-threatening emergencies. First, the patient has severe hyperkalemia with peaked T waves on telemetry. While standard tumor lysis syndrome (TLS) protocols dictate avoiding calcium administration for asymptomatic hypocalcemia (to prevent widespread calcium-phosphate tissue precipitation), the presence of hyperkalemic electrocardiographic changes makes cardioprotection with intravenous calcium gluconate an immediate, absolute necessity. Second, the patient has oliguric acute kidney injury with massive potassium and phosphorus release that cannot be managed medically. Emergent renal replacement therapy (hemodialysis) is definitively required to rapidly clear these electrolytes and manage volume status.

Step-by-Step Solution

Interpret continuous telemetry and serial laboratory data.

Identifies severe hyperkalemia (

6.8 \text{ mEq/L}

) with ECG changes (peaked T waves), severe hyperphosphatemia, profound hypocalcemia, and oliguric acute kidney injury.

Accurate interpretation of post-chemotherapy monitoring is required to establish emergency management priorities.

Stabilize the cardiac membrane.

Administer intravenous calcium gluconate.

Although calcium administration is generally avoided in TLS-associated hypocalcemia to prevent calcium-phosphate precipitation, the presence of hyperkalemia with electrocardiographic changes makes cardioprotection an absolute priority to prevent fatal arrhythmias.

Address severe oliguric acute kidney injury and electrolyte derangements.

Consult nephrology for emergent hemodialysis.

Medical management is insufficient for clearing massive potassium and phosphorus loads in the setting of oliguric renal failure; renal replacement therapy is definitively required.

Key Concept

In Tumor Lysis Syndrome, asymptomatic hypocalcemia should not be treated with calcium due to precipitation risks; however, if hyperkalemia with ECG changes occurs, IV calcium gluconate is mandatorily indicated for cardioprotection alongside emergent hemodialysis.

Question 431Question →

A 72-year-old man is medically stable after a 10-day hospitalization for a severe ischemic stroke. He has significant residual left-sided weakness and requires maximum assistance with activities of daily living. The clinical decision is made to transition him to a skilled nursing facility (SNF) for ongoing physical rehabilitation. Arrange the following steps of the care transition process in the most appropriate chronological sequence to ensure a safe and effective discharge.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence for transitioning a patient to a skilled nursing facility is: 1) Assess the required level of care, 2) Secure facility acceptance, 3) Perform medication reconciliation and write orders, 4) Conduct verbal handoff, and 5) Execute physical transfer with paperwork.

Safe and effective care transitions follow a logical, stepwise protocol to prevent medical errors and readmissions. The process must begin with a clinical assessment to determine the appropriate care setting. Once the need is identified, placement must be secured. Only after a destination is known can the physician accurately perform medication reconciliation and write transfer orders tailored to that facility's capabilities. With the plan finalized, a verbal handoff ensures the receiving clinicians understand the patient's complexities. Finally, the physical transfer occurs with all necessary written documentation.

Step-by-Step Solution

Determine the necessary level of post-acute care

The requirement for a skilled nursing facility is formally established based on the patient's functional deficits.

Disposition planning must always begin with an accurate assessment of patient needs to prevent unsafe discharges.

Coordinate placement with prospective facilities

A specific skilled nursing facility reviews the clinical documentation and formally accepts the patient.

Medical orders and handoffs cannot be finalized until a receiving destination is confirmed.

Finalize the medical transition plan

Medications are reconciled and transfer orders are written specifically for the chosen facility.

The receiving facility requires explicit, updated medical orders to assume care safely.

Communicate directly with the receiving team

A verbal handoff is conducted to discuss the patient's hospital course and anticipated needs.

Direct clinician-to-clinician communication minimizes errors and ensures critical details are not missed in written documents.

Execute the physical transfer

The patient is transported with the written discharge summary and all legal paperwork.

Physical transfer is the culmination of the planning process, requiring all documentation to travel with or ahead of the patient.

Key Concept

Safe transitions of care require a structured, sequential approach: assessing needs, securing a destination, formulating the medical plan, communicating with the receiving team, and ensuring physical transfer of both the patient and their health information.

Question 432Question →

During morning rounds, the intensive care team is consulted regarding a $72$ -year-old female admitted two days prior to the cardiology service. She initially presented with an anterior ST-segment elevation myocardial infarction and underwent successful percutaneous coronary intervention with the placement of a drug-eluting stent in the left anterior descending artery. Her current medical regimen includes aspirin, ticagrelor, atorvastatin, and metoprolol.

Over the last $12$ hours, she has developed worsening, sharp pain in her right upper quadrant. Current vital signs are temperature $39.0^\circ\text{C}$ ( $102.2^\circ\text{F}$ ), heart rate $118/\text{min}$ , blood pressure $102/68\text{ mmHg}$ , and respiratory rate $22/\text{min}$ . Physical examination reveals an absence of scleral icterus but marked tenderness and inspiratory arrest upon palpation of the right upper quadrant. Laboratory studies demonstrate a leukocyte count of $18,200/\text{mm}^3$ . Serum total bilirubin, aspartate aminotransferase, and alkaline phosphatase levels are within normal reference ranges. A bedside right upper quadrant ultrasonogram displays a distended gallbladder with a wall thickness of $6\text{ mm}$ , pericholecystic fluid, and numerous echogenic foci with acoustic shadowing. The common bile duct measures $4\text{ mm}$ in diameter. Intravenous fluids and broad-spectrum antibiotics are initiated.

Which of the following is the most appropriate next step in the procedural management of this patient?

Immediate laparoscopic cholecystectomy

Endoscopic retrograde cholangiopancreatography with sphincterotomy

Percutaneous cholecystostomy tube placement

Administration of fresh frozen plasma followed by urgent cholecystectomy

Discharge to a skilled nursing facility with oral antibiotics and planned interval surgery

Show answer & explanation

Answer: Percutaneous cholecystostomy tube placement

Answer

The correct answer is percutaneous cholecystostomy tube placement.

The correct answer is percutaneous cholecystostomy tube placement. This patient has acute calculous cholecystitis, as evidenced by fever, right upper quadrant pain, leukocytosis, and classic ultrasound findings (thickened gallbladder wall, pericholecystic fluid, gallstones). While laparoscopic cholecystectomy is the standard definitive treatment for acute cholecystitis, this patient is a prohibitively high-risk surgical candidate. She had a drug-eluting stent (DES) placed two days ago for an acute ST-segment elevation myocardial infarction. Discontinuation of dual antiplatelet therapy (DAPT) in the early post-stent period carries a catastrophic risk of in-stent thrombosis and fatal myocardial infarction, while performing major abdominal surgery while on DAPT poses a massive risk of uncontrollable hemorrhage. The physiologic stress of general anesthesia and pneumoperitoneum also severely increases myocardial oxygen demand, risking further ischemia in a recently infarcted heart. Therefore, the most appropriate management to achieve source control of her sepsis without subjecting her to prohibitive surgical risk is the placement of a percutaneous cholecystostomy tube. This minimally invasive procedure decompresses and drains the infected gallbladder, stabilizing the patient until surgery can be safely reconsidered (typically weeks to months later, after the critical period for stent endothelialization has passed, or managed non-operatively if she remains too high risk).

Step-by-Step Solution

Diagnose the acute condition based on clinical presentation.

The patient has acute calculous cholecystitis, as evidenced by right upper quadrant pain, fever, leukocytosis, and classic ultrasound findings (thickened gallbladder wall, pericholecystic fluid, and gallstones without common bile duct dilation).

Establishing the correct diagnosis is essential for determining the need for source control.

Assess the patient's surgical risk and evaluate contraindications.

The patient underwent placement of a drug-eluting stent (DES) two days ago. She requires uninterrupted dual antiplatelet therapy (DAPT). Major surgery poses an unacceptable bleeding risk while on DAPT, and stopping DAPT poses a catastrophic risk of in-stent thrombosis.

Identifying prohibitive surgical risks alters the standard management pathway (laparoscopic cholecystectomy) toward less invasive alternatives.

Select the appropriate definitive or bridging procedural intervention.

Percutaneous cholecystostomy tube placement is selected.

This minimally invasive procedure provides necessary drainage and source control of the infected gallbladder under local anesthesia without the need to discontinue life-saving antiplatelet therapy or expose the patient to the physiologic stress of general anesthesia and surgery.

Key Concept

Surgical and procedural management of acute cholecystitis in prohibitively high-risk patients requires percutaneous cholecystostomy for initial source control.

Question 433Question →

Emergency medical services arrive at the emergency department with a 68-year-old female from a local skilled nursing facility, presenting with acute delirium and severe pyrexia. Her medical background includes type 2 diabetes mellitus, essential hypertension, and a previous ischemic stroke with residual right-sided deficits. Her medication regimen consists of metformin, lisinopril, and daily aspirin. Upon triage, her temperature is $39.4^\circ\text{C}$ ( $102.9^\circ\text{F}$ ), blood pressure is $70/40\text{ mm Hg}$ , heart rate is $128\text{/min}$ , and respiratory rate is $24\text{/min}$ . Peripheral pulse oximetry displays $94\%$ on ambient air. Physical evaluation shows parched oral mucosa, bounding peripheral pulses with flushed skin, and turbid, malodorous urine collecting in her indwelling catheter system.

Laboratory Parameter	Value
Leukocyte count	$22,000\text{/\mu L}$
Serum creatinine	$1.8\text{ mg/dL}$ (baseline $0.9\text{ mg/dL}$ )
Serum lactate	$5.4\text{ mmol/L}$

After securing blood and urine cultures, the clinical team administers broad-spectrum intravenous antibiotics. They immediately turn their focus to correcting her profound hemodynamic collapse.

Arrange the following protocolized pharmacologic interventions in the correct chronological sequence of clinical escalation:

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence of pharmacologic escalation in septic shock is: 1) Rapid administration of intravenous crystalloid fluids, 2) Initiation of norepinephrine infusion, 3) Addition of vasopressin infusion, 4) Administration of intravenous hydrocortisone.

The Surviving Sepsis Campaign guidelines dictate a strict, stepwise algorithmic approach to hemodynamic instability. The absolute first step is a rapid

30\text{ mL/kg}

crystalloid bolus within the first 3 hours to correct absolute and relative hypovolemia. Vasopressors should only be started if the MAP remains

< 65\text{ mm Hg}

after, or concurrently during, adequate fluid resuscitation. Norepinephrine is the primary vasoactive agent of choice. If the MAP is still not maintained despite escalating norepinephrine doses, vasopressin is added to provide synergistic vasoconstriction and spare high-dose catecholamine toxicity. Finally, if the shock remains refractory despite optimized fluids and dual-vasopressor therapy, intravenous hydrocortisone (

200\text{ mg/day}

) is administered to treat relative adrenal insufficiency and downregulate the inflammatory cascade.

Step-by-Step Solution

Administer immediate fluid resuscitation

Restoration of intravascular volume and improvement in cardiac preload

Sepsis causes profound vasodilation and capillary leak. A

30\text{ mL/kg}

crystalloid bolus within the first 3 hours is the required first step to optimize preload before utilizing vasoconstrictive agents.

Initiate first-line vasopressor therapy

Increase in systemic vascular resistance and mean arterial pressure (MAP)

If the MAP remains

< 65\text{ mm Hg}

despite adequate fluid loading, norepinephrine is the guideline-recommended first-line agent due to its potent alpha-1 and mild beta-1 agonism, which improves perfusion without excessive tachycardia.

Escalate to a second-line vasoactive adjunct

Further MAP support and a norepinephrine-sparing effect

When norepinephrine requirements escalate (typically reaching

0.25

0.5\text{ \mu g/kg/min}

), vasopressin is added to target V1 receptors. This provides synergistic vasoconstriction and reduces the catecholamine burden.

Administer systemic corticosteroids

Reversal of critical illness-related corticosteroid insufficiency (CIRCI) and modulation of the systemic inflammatory response

In refractory shock requiring multiple high-dose vasopressors despite adequate fluid resuscitation, intravenous hydrocortisone is indicated to improve vasomotor tone and accelerate shock resolution.

Key Concept

In septic shock, hemodynamic stabilization follows a strict algorithmic sequence: adequate fluid resuscitation must precede or accompany initial vasopressors. Norepinephrine is the primary vasopressor, followed by vasopressin as a secondary adjunct. Corticosteroids are reserved solely for refractory shock.

Estimated Time:2m 30s

Question 434Question →

A $68$ -year-old man presents to the emergency department with severe shortness of breath, orthopnea, and lower extremity swelling that has progressively worsened over the past $3$ days. He has a history of ischemic cardiomyopathy with a left ventricular ejection fraction of $25\%$ , type $2$ diabetes mellitus, and hypertension. His temperature is $37.0$ °C ( $98.6$ °F), blood pressure is $158/92$ mmHg, heart rate is $112$ /min, and respiratory rate is $24$ /min. Oxygen saturation is $88\%$ on room air. Physical examination reveals elevated jugular venous pressure, bilateral crackles extending to the mid-lung fields, and $3+$ bilateral pitting pedal edema. An electrocardiogram shows sinus tachycardia with no acute ischemic changes. Which of the following pharmacologic interventions are indicated for the immediate management of this patient's acute presentation? (Select all that apply)

Select all that apply

Intravenous furosemide

Intravenous nitroglycerin

Oral metoprolol succinate

Intravenous verapamil

Oral pioglitazone

Show answer & explanation

Answer: Intravenous furosemide; Intravenous nitroglycerin

Answer

The correct interventions are intravenous furosemide and intravenous nitroglycerin.

The correct answers address the immediate need for preload reduction in a patient with acute decompensated heart failure (ADHF) and hypertension. Intravenous furosemide is a loop diuretic that rapidly induces diuresis and venodilation, directly relieving pulmonary congestion. Intravenous nitroglycerin is a potent venodilator (and mild arterial dilator) that further reduces preload; it is specifically indicated as an adjunctive therapy for ADHF patients presenting with elevated blood pressure, providing rapid and significant symptomatic relief.

Step-by-Step Solution

Identify the primary clinical syndrome.

The patient presents with acute decompensated heart failure (ADHF) characterized by severe volume overload (pulmonary edema, elevated JVP, peripheral edema) and elevated blood pressure.

Accurate diagnosis determines the required hemodynamic shifts needed for immediate stabilization.

Select appropriate acute symptom-relieving therapies.

Intravenous loop diuretics (furosemide) are chosen to remove excess volume, and intravenous vasodilators (nitroglycerin) are chosen to rapidly reduce preload and afterload.

These agents provide rapid symptomatic improvement in ADHF when systemic blood pressure is adequately elevated.

Identify and avoid contraindicated medications.

Exclude beta-blockers, non-dihydropyridine calcium channel blockers, and thiazolidinediones.

Administering negatively inotropic medications or fluid-retaining agents will acutely worsen cardiogenic pulmonary edema and delay stabilization.

Key Concept

Acute decompensated heart failure with volume overload and hypertension requires immediate preload reduction using intravenous loop diuretics and vasodilators, while strictly avoiding negatively inotropic or fluid-retaining medications.

Estimated Time:1m 0s

Question 435Question →

A 42-year-old woman is newly diagnosed with primary hypothyroidism and is initiated on standard daily weight-based levothyroxine therapy. She asks her physician about the protocol for checking her thyroid function and adjusting her medication going forward. Arrange the following steps in the correct chronological sequence for the standard monitoring and adjustment of her levothyroxine therapy.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is to first evaluate TSH at 6 weeks, then titrate the dose based on that result, subsequently recheck TSH 6 weeks after the adjustment, and finally transition to annual monitoring once a stable euthyroid state is achieved.

The correct chronological sequence for monitoring and adjusting levothyroxine therapy begins with checking the serum TSH level 6 weeks after initiating treatment. Levothyroxine has a long half-life of approximately 7 days, meaning it takes about 5 to 6 half-lives (roughly 6 weeks) to reach steady-state serum concentrations. Once the steady-state TSH is evaluated, the dose is titrated if the TSH remains outside the target reference range. Any dose adjustment resets the pharmacokinetic timeline, requiring another 6-week waiting period before a new steady-state TSH can be accurately measured. Finally, once the patient is on a consistent dose that maintains a stable, normal TSH level, the monitoring interval can be safely extended to an annual basis.

Step-by-Step Solution

Identify the time required for levothyroxine to reach steady state after initiation.

Approximately 6 weeks (5 to 6 half-lives).

Checking TSH before 6 weeks will yield an inaccurate assessment of the current dose's true effect on the body.

Determine the next action based on the 6-week TSH result.

Titrate the levothyroxine dose if TSH is not at the target goal.

Dose adjustments are required to achieve and maintain a euthyroid state if the initial dose was insufficient or excessive.

Determine the monitoring interval following a dose adjustment.

Wait another 6 weeks to recheck the TSH.

Any dose change resets the timeline required to reach a new steady state.

Establish the long-term monitoring plan once the patient is clinically stable.

Monitor TSH annually.

Once the patient is euthyroid on a stable dose, frequent monitoring is unnecessary and annual checks are sufficient.

Key Concept

Chronological protocol for monitoring and adjusting levothyroxine therapy based on its pharmacokinetic steady-state principles

Question 436Question →

A 54-year-old woman is brought to the emergency department via ambulance after the sudden onset of severe, tearing chest pain that radiates to her interscapular region. Her medical history is significant for severe persistent asthma, for which she takes an inhaled corticosteroid and long-acting beta-agonist, and hypertension, for which she takes amlodipine. On arrival, she appears in acute distress. Her temperature is $37.1^\circ\text{C}$ ( $98.8^\circ\text{F}$ ), blood pressure is $215/115\text{ mmHg}$ in the right arm and $185/95\text{ mmHg}$ in the left arm, heart rate is $118\text{/min}$ , and respiratory rate is $24\text{/min}$ . Pulse oximetry shows $94\%$ on room air. Physical examination reveals a diaphoretic woman. Pulmonary auscultation reveals diffuse bilateral expiratory wheezing. Cardiovascular examination shows a regular tachycardic rhythm with no murmurs, rubs, or gallops. Radial pulses are symmetric, but the left femoral pulse is diminished. CT angiography of the chest confirms a Stanford type B aortic dissection. Which of the following is the most appropriate initial pharmacologic intervention for this patient?

Intravenous esmolol followed by intravenous sodium nitroprusside

Intravenous sodium nitroprusside alone

Intravenous diltiazem followed by intravenous sodium nitroprusside

Intravenous labetalol

Intravenous nicardipine followed by intravenous diltiazem

Show answer & explanation

Answer: Intravenous diltiazem followed by intravenous sodium nitroprusside

Answer

Intravenous diltiazem followed by intravenous sodium nitroprusside

The correct sequence for the medical management of acute aortic dissection is strict heart rate control followed by blood pressure control. The primary goal is to reduce aortic wall shear stress (

dp/dt

). While intravenous beta-blockers (such as esmolol or labetalol) are the standard first-line agents, this patient has severe persistent asthma with active diffuse wheezing. Beta-blockers are contraindicated in active asthma exacerbations as they can precipitate severe bronchospasm. According to major cardiovascular guidelines, in patients with acute aortic dissection who have absolute contraindications to beta-blockers, intravenous non-dihydropyridine calcium channel blockers (e.g., diltiazem or verapamil) should be used as the initial agent for heart rate control. Once the heart rate is controlled, an intravenous vasodilator such as sodium nitroprusside is added to achieve the target systolic blood pressure.

Step-by-Step Solution

Identify the primary diagnosis and its immediate physiologic threat.

The patient has a Stanford type B aortic dissection, which requires immediate reduction of aortic wall shear stress (

dp/dt

High blood pressure and a fast heart rate increase the rate of rise of ventricular pressure, which actively propagates the dissection flap.

Determine the standard pharmacologic protocol for the diagnosis.

The standard sequence is heart rate control (target

< 60\text{/min}

) followed by blood pressure control (target systolic

< 120\text{ mmHg}

) using an intravenous beta-blocker followed by a vasodilator.

Reversing the sequence or using vasodilators alone causes reflex tachycardia, which worsens the dissection.

Evaluate the patient's comorbidities for contraindications to standard therapy.

The patient has severe persistent asthma with active diffuse wheezing, making beta-blockers (like esmolol or labetalol) strongly contraindicated.

Even cardioselective beta-blockers can precipitate life-threatening bronchospasm in active asthma.

Select the appropriate alternative therapy.

Intravenous diltiazem is selected as the initial agent for heart rate control, followed by sodium nitroprusside for blood pressure control.

Non-dihydropyridine calcium channel blockers effectively reduce heart rate and contractility without exacerbating bronchospasm.

Key Concept

In the medical management of acute aortic dissection, beta-blockers are the first-line agents to reduce heart rate and blood pressure. However, in patients with absolute contraindications to beta-blockers, such as active severe asthma, non-dihydropyridine calcium channel blockers (e.g., diltiazem, verapamil) must be used before initiating vasodilator therapy.

Estimated Time:1m 30s

Question 437Question →

While rounding in the medical intensive care unit, a physician evaluates the laboratory profile of a 62-year-old woman being treated for septic shock secondary to a urinary tract infection. The patient has a 10-year history of focal impaired awareness seizures and takes oral phenytoin $300$ mg daily. Currently, she is mechanically ventilated, receiving a continuous norepinephrine infusion, and deeply sedated. The nursing staff reports no abnormal movements or clinical seizure activity over the past $48$ hours.

Laboratory results from this morning are compared to her admission baseline:

Parameter	Admission (Day 1)	Current (Day 3)	Reference Range
Blood urea nitrogen	$18$ mg/dL	$72$ mg/dL	$7-20$ mg/dL
Serum creatinine	$1.0$ mg/dL	$3.4$ mg/dL	$0.6-1.2$ mg/dL
Serum albumin	$3.6$ g/dL	$1.8$ g/dL	$3.5-5.0$ g/dL
Total serum phenytoin	$12.4$ $\mu$ g/mL	$6.5$ $\mu$ g/mL	$10-20$ $\mu$ g/mL

Which of the following is the most appropriate next step regarding the patient's antiseizure therapy?

Obtain a free serum phenytoin concentration

Increase the maintenance dosage of phenytoin

Administer an intravenous loading dose of fosphenytoin

Discontinue phenytoin and initiate intravenous valproic acid

Initiate continuous video electroencephalography monitoring

Show answer & explanation

Answer: Obtain a free serum phenytoin concentration

Answer

The most appropriate next step is to obtain a free serum phenytoin concentration to accurately assess the pharmacologically active drug level.

The correct next step is to obtain a free serum phenytoin concentration. Phenytoin is a highly protein-bound drug (typically

\sim 90\%

bound to serum albumin). In critically ill patients with severe hypoalbuminemia, the number of binding sites is reduced, leading to a precipitous decrease in the bound fraction of the drug. This causes the total serum phenytoin level to appear subtherapeutic. Additionally, in the setting of severe uremia (as seen with this patient's acute kidney injury, with a BUN of

72

mg/dL), retained endogenous organic acids directly displace phenytoin from its remaining binding sites on albumin, further increasing the free (unbound, pharmacologically active) fraction of the drug. Because the patient is clinically stable from a neurologic standpoint with no seizure activity, the low total phenytoin level is almost certainly an artifact of decreased protein binding rather than true subtherapeutic dosing. The active, free phenytoin level is likely within or even above the therapeutic range (

1-2

\mu

g/mL). Increasing the dose without checking a free level could precipitate severe phenytoin toxicity, which manifests as arrhythmias, cardiovascular collapse, nystagmus, and ataxia. Therefore, the safest and most guideline-concordant monitoring step is to measure the free serum phenytoin concentration before making any therapeutic adjustments.

Step-by-Step Solution

Analyze the patient's clinical status and longitudinal laboratory trends.

The patient is critically ill with newly developed acute kidney injury and significant hypoalbuminemia, but shows no clinical signs of breakthrough seizures.

Establishing the clinical context and identifying end-organ dysfunction is required before interpreting pharmacokinetic markers.

Interpret the total phenytoin level in the context of the patient's altered physiology.

Phenytoin is highly protein-bound; the patient's low albumin and uremia decrease binding capacity, artifactually lowering the total phenytoin level while leaving the unbound (free) fraction unchanged or elevated.

Endogenous uremic toxins displace phenytoin from albumin, and the absolute lack of albumin further decreases the storage capacity for the bound fraction of the drug.

Determine the most appropriate monitoring intervention to guide therapy.

A free (unbound) phenytoin level must be measured before making any dosage changes.

Because the total level is an unreliable artifact in this setting, adjusting the dose without confirming the free level risks severe iatrogenic toxicity.

Key Concept

In critically ill patients with severe hypoalbuminemia or uremia, total serum phenytoin levels may appear falsely subtherapeutic due to decreased protein binding capacity; a free phenytoin concentration must be checked before adjusting the dose.

Alternative Method

The expected active drug level can be estimated mathematically by correcting the total phenytoin concentration for hypoalbuminemia and end-stage renal disease using the modified Sheiner-Tozer equation:

Adjusted\ Total = \frac{\text{Measured Total}}{0.1 \times \text{Albumin} + 0.1}

. Using this patient's values, her adjusted total phenytoin is mathematically estimated to be

\frac{6.5}{(0.1 \times 1.8) + 0.1} = 23.2

\mu

g/mL, indicating she is actually supratherapeutic despite a 'low' measured total level. However, direct measurement of the free level is the clinical gold standard.

Estimated Time:1m 30s

Question 438Question →

A 65-year-old man is evaluated in the intensive care unit. He was admitted 12 days ago for status epilepticus and subsequently developed ventilator-associated pneumonia. He was intubated and received continuous enteral nutrition via a nasogastric tube. His seizures have been well controlled on enteral phenytoin suspension, requiring a high dose of 400 mg every 8 hours to maintain a therapeutic total serum trough level of 16 mcg/mL. His pneumonia is being treated with intravenous meropenem.

Today, the patient's respiratory status has significantly improved, and he is extubated. The continuous enteral feeds are discontinued, and he successfully passes a swallowing evaluation. He is advanced to a standard oral diet and is scheduled to transition to oral phenytoin capsules. His serum albumin is 3.5 g/dL. Renal and hepatic functions are within normal limits.

Which of the following is the most appropriate next step in the management of this patient's pharmacotherapy?

Empirically reduce the phenytoin dose and closely monitor serum trough levels

Continue the same total daily dose of phenytoin and monitor for clinical signs of nystagmus or ataxia

Measure a serum free phenytoin level to account for the transition from suspension to capsules

Substitute meropenem with cefepime to prevent accelerated hepatic clearance of the antiepileptic

Maintain the same total daily dose but check a trough level 1 hour after the first oral capsule dose

Show answer & explanation

Answer: Empirically reduce the phenytoin dose and closely monitor serum trough levels

Answer

Empirically reduce the phenytoin dose and closely monitor serum trough levels

The correct answer is to empirically reduce the phenytoin dose and closely monitor serum trough levels. Continuous enteral nutrition formulas physically bind to phenytoin in the gastrointestinal tract, significantly impairing its absorption. To achieve therapeutic serum levels while on continuous feeds, patients often require exceptionally high compensatory doses (e.g., 1200 mg/day, as seen in this patient). When enteral feeding is discontinued and the patient transitions to a standard oral diet, this binding interaction is eliminated, leading to a sudden and massive increase in phenytoin bioavailability. Because phenytoin exhibits saturable, Michaelis-Menten (zero-order) pharmacokinetics at therapeutic concentrations, continuing the high compensatory dose will rapidly result in severe toxicity. Therefore, the dose must be empirically reduced, followed by vigilant trough level monitoring.

Step-by-Step Solution

Identify the patient's current clinical transition and relevant medication.

The patient is taking phenytoin and is transitioning from continuous enteral nutrition to a standard oral diet.

Recognizing changes in diet or feeding routes is critical for highly bound or poorly absorbed medications.

Evaluate the current medication dosage in the context of the feeding route.

The patient requires a massive dose of 1200 mg/day (400 mg every 8 hours) to maintain therapeutic levels, which is far above the standard maintenance dose.

Enteral nutrition formulas physically bind to phenytoin suspension in the gastrointestinal tract, significantly impairing its absorption and necessitating high compensatory doses.

Predict the pharmacokinetic consequence of discontinuing the enteral feeds.

Removing the enteral feeds eliminates the binding interaction, leading to a sudden and massive increase in the amount of bioavailable phenytoin absorbed from the gastrointestinal tract.

Phenytoin exhibits saturable, Michaelis-Menten (zero-order) pharmacokinetics at therapeutic concentrations, meaning any increase in absorption will disproportionately elevate serum levels.

Determine the most appropriate proactive clinical intervention.

Empirically reduce the phenytoin dose to a standard maintenance level and closely monitor serum trough levels.

Maintaining the compensatory high dose without enteral feeds will rapidly lead to severe neurological toxicity.

Key Concept

Pharmacokinetic interaction between continuous enteral nutrition and phenytoin absorption

Estimated Time:1m 30s

Question 439Question →

A 58-year-old male is brought to the emergency department by his spouse due to sudden-onset neurological deficits. Approximately 45 minutes prior to arrival, he abruptly developed difficulty speaking and right-sided weakness while eating dinner. His medical history is significant for essential hypertension and hyperlipidemia, for which he takes amlodipine and atorvastatin. He has no history of bleeding disorders and does not take any anticoagulant medications. Vital signs show a blood pressure of 175/95 mmHg, heart rate of 82/min, and respiratory rate of 16/min. Neurologic examination reveals expressive aphasia, a right-sided facial droop, and 2/5 muscle strength in the right upper and lower extremities. The clinical team is evaluating the patient for acute reperfusion therapy with intravenous alteplase. Which of the following diagnostic studies MUST be obtained and their results reviewed prior to the administration of this therapy? (Select all that apply)

Select all that apply

Point-of-care blood glucose measurement

Non-contrast computed tomography of the head

Complete coagulation profile (PT, INR, and aPTT)

Magnetic resonance imaging of the brain without contrast

12-lead electrocardiogram

Show answer & explanation

Answer: Point-of-care blood glucose measurement; Non-contrast computed tomography of the head

Answer

The correct diagnostic studies that must be obtained and reviewed prior to thrombolytic therapy are point-of-care blood glucose measurement and non-contrast computed tomography of the head.

For a patient presenting with an acute ischemic stroke, the American Heart Association/American Stroke Association (AHA/ASA) guidelines dictate that time is brain. The only test results absolutely required before initiating intravenous alteplase (tPA) in a typical patient are a non-contrast head CT (to definitively rule out intracranial hemorrhage) and a blood glucose assessment (to rule out hypoglycemia, which can present as a stroke mimic). Delaying reperfusion for any other testing reduces the likelihood of a favorable neurological outcome.

Step-by-Step Solution

Identify the patient's clinical presentation and the proposed intervention.

The patient is presenting with signs of an acute ischemic stroke within the 4.5-hour therapeutic window for intravenous alteplase (tPA).

Establishing the timeline and likely diagnosis dictates the urgency and specific pathway of the diagnostic workup.

Determine the absolute requirements prior to administering intravenous thrombolytics.

The guidelines mandate ruling out two critical conditions: hypoglycemia (which can mimic a stroke) and intracranial hemorrhage (which is an absolute contraindication to tPA).

Administering tPA to a patient with a hemorrhage is often fatal, and giving it to a patient with isolated hypoglycemia exposes them to unnecessary bleeding risks without any benefit.

Select the appropriate tests to rule out these contraindications without delaying care.

A point-of-care blood glucose measurement is selected to rule out hypoglycemia, and a rapid non-contrast head CT is selected to exclude hemorrhage.

Both tests are highly sensitive for their respective rule-outs and can be performed quickly, minimizing door-to-needle time.

Key Concept

In patients presenting with suspected acute ischemic stroke who are candidates for thrombolytic therapy, the only diagnostic tests that must invariably be performed and reviewed prior to the administration of intravenous alteplase are a non-contrast head CT (or MRI) and a blood glucose measurement.

Question 440Question →

A 62-year-old woman comes to the outpatient clinic reporting a 2-day history of dysuria and increased urinary frequency. She denies fever, chills, flank pain, nausea, or vomiting. Her medical history is significant for hypertension and a mechanical mitral valve replacement performed 4 years ago, for which she is on chronic anticoagulation. Current medications include warfarin, lisinopril, and metoprolol. Her temperature is 37.1°C (98.8°F), blood pressure is 128/82 mm Hg, and pulse is 76/min. Physical examination reveals mild suprapubic tenderness to palpation but no costovertebral angle tenderness.

Laboratory studies show:

Test	Result
Serum creatinine	0.9 mg/dL
INR	2.6

Urinalysis

Parameter	Result
Color	Yellow
Specific gravity	1.018
pH	6.5
Protein	Negative
Blood	Trace
Leukocyte esterase	Positive
Nitrites	Positive
WBC	35/hpf
RBC	3/hpf

Which of the following is the most appropriate pharmacologic intervention?

Oral amoxicillin

Oral ciprofloxacin

Oral nitrofurantoin

Oral trimethoprim-sulfamethoxazole

Intravenous ceftriaxone

Show answer & explanation

Answer: Oral nitrofurantoin

Answer

Oral nitrofurantoin

The patient presents with acute uncomplicated cystitis. First-line empiric therapies for uncomplicated cystitis include oral nitrofurantoin, trimethoprim-sulfamethoxazole (TMP-SMX), and fosfomycin. However, this patient's medication regimen includes warfarin for a mechanical heart valve. TMP-SMX is a potent inhibitor of cytochrome P450 2C9 (CYP2C9), which is the primary enzyme responsible for metabolizing the more active S-enantiomer of warfarin. Co-administration of TMP-SMX and warfarin significantly decreases warfarin clearance, leading to a rapid, profound increase in the international normalized ratio (INR) and elevating the risk of severe hemorrhage. Therefore, oral nitrofurantoin is the most appropriate first-line pharmacologic intervention, as it provides excellent concentration in the urine, effectively covers common uropathogens (e.g., E. coli), and does not clinically interact with warfarin.

Step-by-Step Solution

Diagnose uncomplicated acute cystitis.

The patient has dysuria, frequency, and a supportive urinalysis (positive leukocyte esterase, nitrites, WBCs) without systemic signs of infection.

Establishing the correct diagnosis allows for the selection of appropriate empiric antimicrobial therapy.

Identify concurrent high-risk medications.

The patient is taking warfarin for a mechanical heart valve and has a therapeutic INR of 2.6.

Warfarin has a narrow therapeutic index and is highly susceptible to drug-drug interactions that can lead to catastrophic bleeding or thrombosis.

Evaluate first-line empiric antibiotic options for interactions.

First-line agents include nitrofurantoin, trimethoprim-sulfamethoxazole (TMP-SMX), and fosfomycin. TMP-SMX heavily interacts with warfarin.

TMP-SMX inhibits CYP2C9, the primary enzyme that metabolizes the active S-enantiomer of warfarin, leading to dangerously elevated INR levels.

Select the optimal safe pharmacologic intervention.

Oral nitrofurantoin is selected.

It provides excellent urinary concentration and uropathogen coverage without significantly interacting with warfarin.

Key Concept

In patients taking warfarin, trimethoprim-sulfamethoxazole should be avoided for the treatment of uncomplicated cystitis due to severe CYP2C9 inhibition leading to increased bleeding risk; alternative first-line agents like nitrofurantoin or fosfomycin are preferred.

PreviousPage 22 / 104Next

Patient Management

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Alternative Method

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution